|
⚲
|
| Keyboard |
| Adimab LLC
✚
|
|
|---|---|
| CIK # | 0001545672 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001545672] | |
| 4 | [0001545672] | |
| D | [0001545672] | |
| SC 13D | [0001545672] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Adimab LLC | Adagio Therapeutics Inc | [2022-03-30] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Adimab LLC | |
| Invivyd Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Invivyd Inc IVVD
Common Stock
|
2024-01-19 | Sell | 5,000,000 | $3.95 | 19,750,000 |
|
Invivyd Inc ADGI
Common Stock
|
2022-03-03 | Other | 1,158,089 | ||
|
Invivyd Inc ADGI
Common Stock
|
2021-08-10 | Conversion | 25,860,700 | ||
|
Invivyd Inc ADGI
Series B Preferred Stock · derivative
|
2021-08-10 | Conversion | 44,076 | $0.00 | |
|
Invivyd Inc ADGI
Series A Preferred Stock · derivative
|
2021-08-10 | Conversion | 5,000,000 | $0.00 | |
|
Invivyd Inc ADGI
Series C Preferred Stock · derivative
|
2021-08-10 | Conversion | 128,064 | $0.00 |